TP53 and crescentic glomerulonephritis: We had previously shown that Nutlin‐3a, another MDM2 inhibitor, has protective effects in postischemic acute kidney injury 12 and crescentic glomerulonephritis 13 via p53‐independent NFκB signal inhibition.